NCT03957356View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 19, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

July 8, 2020

Conditions
Hemorrhage
Interventions
DEVICE

HLBLS-200

The amount of HLBLS-200 applied will be determined by the investigator based on the resection area.

Trial Locations (1)

04763

Hanyang Univ. Medical Center, Seoul

All Listed Sponsors
lead

HLB Cell Co., Ltd.

INDUSTRY

NCT03957356 - Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique | Biotech Hunter | Biotech Hunter